634 related articles for article (PubMed ID: 31171889)
1. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats.
Zhao ZH; Xin FZ; Zhou D; Xue YQ; Liu XL; Yang RX; Pan Q; Fan JG
World J Gastroenterol; 2019 May; 25(20):2450-2462. PubMed ID: 31171889
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
[TBL] [Abstract][Full Text] [Related]
3. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
4. Folic acid attenuates high-fat diet-induced steatohepatitis
Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
6. Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet.
Whang E; Liu Y; Kageyama S; Woo SL; Yang J; Lee R; Li Z; Ji H; Chen Y; Kupiec-Weglinski JW
Obes Surg; 2019 Aug; 29(8):2420-2429. PubMed ID: 30982168
[TBL] [Abstract][Full Text] [Related]
7. Age-Related Alterations of Nonalcoholic Steatohepatitis in Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.
Omagari K; Asakawa E; Sasao M; Narita S; Hisano M; Fukuda A; Suruga K; Ichimura M; Tsuneyama K
J Nutr Sci Vitaminol (Tokyo); 2019; 65(4):349-356. PubMed ID: 31474685
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis.
Chen D; Xiong J; Chen G; Zhang Z; Liu Y; Xu J; Xu H
In Vivo; 2023; 37(5):2105-2127. PubMed ID: 37652508
[TBL] [Abstract][Full Text] [Related]
9. Stigmasterol Protects Against Steatohepatitis Induced by High-Fat and High-Cholesterol Diet in Mice by Enhancing the Alternative Bile Acid Synthesis Pathway.
Xin Y; Li X; Zhu X; Lin X; Luo M; Xiao Y; Ruan Y; Guo H
J Nutr; 2023 Jul; 153(7):1903-1914. PubMed ID: 37269906
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system.
Chen M; Hou P; Zhou M; Ren Q; Wang X; Huang L; Hui S; Yi L; Mi M
Clin Nutr; 2020 Apr; 39(4):1264-1275. PubMed ID: 31189495
[TBL] [Abstract][Full Text] [Related]
11. A Diterpenoid, 14-Deoxy-11, 12-Didehydroandrographolide, in
Liu YT; Chen HW; Lii CK; Jhuang JH; Huang CS; Li ML; Yao HT
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085637
[TBL] [Abstract][Full Text] [Related]
12. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
13. Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis.
Zhou D; Zhang J; Xiao C; Mo C; Ding BS
Front Immunol; 2022; 13():964477. PubMed ID: 36072588
[TBL] [Abstract][Full Text] [Related]
14. Effects and therapeutic mechanism of Yinzhihuang on steatohepatitis in rats induced by a high-fat, high-cholesterol diet.
Zeng J; Liu XL; Xin FZ; Zhao ZH; Shao YL; Yang RX; Pan Q; Fan JG
J Dig Dis; 2020 Mar; 21(3):179-188. PubMed ID: 31950587
[TBL] [Abstract][Full Text] [Related]
15. Intestinal absorption and hepatic elimination of drugs in high-fat high-cholesterol diet-induced non-alcoholic steatohepatitis rats: exemplified by simvastatin.
Li Z; Zhang J; Zhang Y; Zhou L; Zhao J; Lyu Y; Poon LH; Lin Z; To KKW; Yan X; Zuo Z
Br J Pharmacol; 2021 Feb; 178(3):582-599. PubMed ID: 33119943
[TBL] [Abstract][Full Text] [Related]
16. High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine.
Panasevich MR; Meers GM; Linden MA; Booth FW; Perfield JW; Fritsche KL; Wankhade UD; Chintapalli SV; Shankar K; Ibdah JA; Rector RS
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E78-E92. PubMed ID: 28899857
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
18. Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
Christensen CU; Glavind E; Thomsen KL; Kim YO; Heebøll S; Schuppan D; Hamilton-Dutoit S; Würtz Heegaard C; Grønbæk H
PLoS One; 2018; 13(3):e0192728. PubMed ID: 29522534
[TBL] [Abstract][Full Text] [Related]
19. [Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver].
Suzuki S; Sato Y; Umegaki K; Chiba T
Yakugaku Zasshi; 2016; 136(9):1297-305. PubMed ID: 27592832
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
